Literature DB >> 15825108

Biomarkers as a first-line estimate of injury in chronic liver diseases: time for a moratorium on liver biopsy?

Thierry Poynard, Vlad Ratziu, Yves Benhamou, Dominique Thabut, Joseph Moussalli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15825108     DOI： 10.1053/j.gastro.2005.02.056

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  15 in total

1.  Applicability and variability of liver stiffness measurements according to probe position.

Authors:  Patrick Ingiliz; Kim Pav Chhay; Mona Munteanu; Pascal Lebray; Yen Ngo; Dominique Roulot; Yves Benhamou; Dominique Thabut; Vlad Ratziu; Thierry Poynard
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

2.  Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis.

Authors:  Carmen Fierbinteanu-Braticevici; Ion Dina; Ana Petrisor; Laura Tribus; Lucian Negreanu; Catalin Carstoiu
Journal:  World J Gastroenterol       Date:  2010-10-14       Impact factor: 5.742

3.  Assessment of liver fibrosis: noninvasive means.

Authors:  Thierry Poynard; Rachel Morra; Patrick Ingiliz; Françoise Imbert-Bismut; Dominique Thabut; Djamila Messous; Mona Munteanu; Julien Massard; Yves Benhamou; Vlad Ratziu
Journal:  Saudi J Gastroenterol       Date:  2008-10       Impact factor: 2.485

Review 4.  Non-invasive diagnosis of hepatitis B virus-related cirrhosis.

Authors:  Sangheun Lee; Do Young Kim
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

5.  Exceeding the limits of liver histology markers.

Authors:  Shruti H Mehta; Bryan Lau; Nezam H Afdhal; David L Thomas
Journal:  J Hepatol       Date:  2008-10-18       Impact factor: 25.083

Review 6.  Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage.

Authors:  Pamela Valva; Daniela A Ríos; Elena De Matteo; Maria V Preciado
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

7.  The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.

Authors:  Pamela Valva; Paola Casciato; Juan M Diaz Carrasco; Adrian Gadano; Omar Galdame; María Cristina Galoppo; Eduardo Mullen; Elena De Matteo; María Victoria Preciado
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

8.  Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.

Authors:  Vlad Ratziu; Julien Massard; Frederic Charlotte; Djamila Messous; Françoise Imbert-Bismut; Luninita Bonyhay; Mohamed Tahiri; Mona Munteanu; Dominique Thabut; Jean François Cadranel; Brigitte Le Bail; Victor de Ledinghen; Thierry Poynard
Journal:  BMC Gastroenterol       Date:  2006-02-14       Impact factor: 3.067

9.  Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children.

Authors:  Pamela Valva; Paola Casciato; Carol Lezama; Marcela Galoppo; Adrián Gadano; Omar Galdame; María Cristina Galoppo; Eduardo Mullen; Elena De Matteo; María Victoria Preciado
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

10.  Meta-analyses of FibroTest diagnostic value in chronic liver disease.

Authors:  Thierry Poynard; Rachel Morra; Philippe Halfon; Laurent Castera; Vlad Ratziu; Françoise Imbert-Bismut; Sylvie Naveau; Dominique Thabut; Didier Lebrec; Fabien Zoulim; Marc Bourliere; Patrice Cacoub; Djamila Messous; Mona Munteanu; Victor de Ledinghen
Journal:  BMC Gastroenterol       Date:  2007-10-15       Impact factor: 3.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.